Chargement en cours...
Diabetes mellitus secondary to treatment with immune checkpoint inhibitors
Cancer immunotherapy has been one of the highlights in the advancement of cancer care. Certain immune checkpoint inhibitors bind to PD-1 on T cells and mediate an antitumour immune response. Given that immune checkpoint inhibitors are becoming part of standard care, a new class of adverse events—imm...
Enregistré dans:
| Publié dans: | Curr Oncol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Multimed Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6380640/ https://ncbi.nlm.nih.gov/pubmed/30853817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4151 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|